阪大消化器内科のご紹介・研究実績



2012年

種類

  1. Inoue T, Iijima H, Nakajima S, Shinzaki S, Nishida T, Kanto T, Tsujii M, Wada Y, Miyoshi E, Takehara T.
    O-linked oligosaccharide alterations of IgA1 are a novel biological marker of patients with inflammatory bowel disease.
    Dig Dis Sci. 2012;18: 1723-34.
  2. Shigekawa M, Hikita H, Kodama T, Shimizu S, Li W, Uemura A, Miyagi T, Hosui A, Kanto T, Hiramatsu N, Tatsumi T, Takeda K, Akira S, Takehara T.
    Pancreatic STAT3 protects mice against caerulein-induced pancreatitis via PAP1 induction.
    Am J Pathol. 2012;181:2105-13.
  3. Yamamoto S, Nishida T, Kato M, Inoue T, Hayashi Y, Kondo J, Akasaka T, Yamada T, Shinzaki S, Iijima H, Tsujii M, Takehara T.
    Evaluation of endoscopic ultrasound image quality is necessary in endosonographic assessment of early gastric cancer invasion depth.
    Gastroenterol Res Pract. 2012:194530.
  4. Iijima H, Shinzaki S, Takehara T.
    The importance of vitamins D and K for the bone health and immune function in inflammatory bowel disease.
    Curr Opin Clin Nutr Metab Care. 2012;15:635-40.
  5. Nawa T, Ishida H, Tatsumi T, Li W, Shimizu S, Kodama T, Hikita H, Hosui A, Miyagi T, Kanto T, Hiramatsu N, Hayashi N, Takehara T.
    Interferon-α suppresses hepatitis B virus enhancer II activity via the protein kinase C pathway.
    Virology. 2012;432:452-9.
  6. Kakita N, Kanto T, Itose I, Kuroda S, Inoue M, Matsubara T, Higashitani K, Miyazaki M, Sakakibara M, Hiramatsu N, Takehara T, Kasahara A, Hayashi N.
    Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells.
    Int J Cancer. 2012;131:2573-83.
  7. Hikita H, Kodama T, Shimizu S, Li W, Shigekawa M, Tanaka S, Hosui A, Miyagi T, Tatsumi T, Kanto T, Hiramatsu N, Morii E, Hayashi N, Takehara T.
    Bak deficiency inhibits liver carcinogenesis: a causal link between apoptosis and carcinogenesis.
    J Hepatol. 2012;57:92-100.
  8. Shen S, Niso-Santano M, Adjemian S, Takehara T, Malik SA, Minoux H, Souquere S, Marino G, Lachkar S, Senovilla L, Galluzzi L, Kepp O, Pierron G, Maiuri MC, Hikita H, Kroemer R, Kroemer G.
    Cytoplasmic STAT3 represses autophagy by inhibiting PKR activity.
    Mol Cell. 2012;48:667-80.
  9. Shinzaki S, Iijima H, Fujii H, Kuroki E, Tatsunaka N, Inoue T, Nakajima S, Egawa S, Kanto T, Tsujii M, Morii E, Takeishi S, Asano M, Takehara T, Hayashi N, Miyoshi E.
    Altered oligosaccharide structures reduce colitis induction in mice defective in ?-1,4-galactosyltransferase.
    Gastroenterology. 2012;142:1172-82.
  10. Yamamoto S, Watabe K, Araki H, Kamada Y, Kato M, Kizu T, Kiso S, Tsutsui S, Tsujii M, Kihara S, Funahashi T, Shimomura I, Hayashi N, Takehara T.
    Protective role of adiponectin against ethanol-induced gastric injury in mice.
    Am J Physiol Gastrointest Liver Physiol. 2012;302:G773-80.
  11. Kohga K, Tatsumi T, Tsunematsu H, Aono S, Shimizu S, Kodama T, Hikita H, Yamamoto M, Oze T, Aketa H, Hosui A, Miyagi T, Ishida H, Hiramatsu N, Kanto T, Hayashi N, Takehara T.
    Interleukin-1β enhances the production of soluble MICA in human hepatocellular carcinoma.
    Cancer Immunol Immunother. 2012;61:1425-32.
  12. Kamada Y, Mori K, Matsumoto H, Kiso S, Yoshida Y, Shinzaki S, Hiramatsu N, Ishii M, Moriwaki K, Kawada N, Takehara T, Miyoshi E.
    N-Acetylglucosaminyltransferase V regulates TGF-β response in hepatic stellate cells and the progression of steatohepatitis.
    Glycobiology. 2012;22:778-87.
  13. Inoue T, Iijima H, Tajiri M, Shinzaki S, Shiraishi E, Hiyama S, Mukai A, Nakajima S, Iwatani H, Nishida T, Mizushima T, Yasui T, Isaka Y, Kanto T, Tsujii M, Miyoshi E, Wada Y, Takehara T.
    Deficiency of N-acetylgalactosamine in O-linked oligosaccharides of IgA is a novel biologic marker for Crohn's disease.
    Inflamm Bowel Dis. 2012;18:1723-34.
  14. Kurokawa M, Hiramatsu N, Oze T, Yakushijin T, Miyazaki M, Hosui A, Miyagi T, Yoshida Y, Ishida H, Tatsumi T, Kiso S, Kanto T, Kasahara A, Iio S, Doi Y, Yamada A, Oshita M, Kaneko A, Mochizuki K, Hagiwara H, Mita E, Ito T, Inui Y, Katayama K, Yoshihara H, Imai Y, Hayashi E, Hayashi N, Takehara T.
    Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis B virus infection.
    J Gastroenterol. 2012;47:577-85.
  15. Kawaguchi T, Mochizuki K, Kizu T, Miyazaki M, Yakushijin T, Tsutsui S, Morii E, Takehara T.
    Inflammatory pseudotumor of the liver and spleen diagnosed by percutaneous needle biopsy.
    World.J Gastroenterol. 2012;18:90-5.
  16. Oze T, Hiramatsu N, Song C, Yakushijin T, Iio S, Doi Y, Oshita M, Hagiwara H, Mita E, Ito T, Inui Y, Hijioka T, Tamura S, Yoshihara H, Inoue A, Imai Y, Hayashi E, Kato M, Miyazaki M, Hosui A, Miyagi T, Yoshida Y, Tatsumi T, Kiso S, Kanto T, Kasahara A, Hayashi N, Takehara T.
    Reducing Peg-IFN doses causes later virologic response or no response in HCV genotype 1 patients treated with Peg-IFN alfa-2b plus ribavirin.
    J Gastroenterol. 2012;47:334-42.
  17. Kanto T, Inoue M, Oze T, Miyazaki M, Sakakibara M, Kakita N, Matsubara T, Higashitani K, Hagiwara H, Iio S, Katayama K, Mita E, Kasahara A, Hiramatsu N, Takehara T, Hayashi N.
    Dynamics of regulatory T cells and plasmacytoid dendritic cells as immune markers for virological response in pegylated interferon-α and ribavirin therapy for chronic hepatitis C patients.
    J Gastroenterol. 2012;47:169-78.
  18. Shimizu S, Takehara T, Hikita H, Kodama T, Tsunematsu H, Miyagi T, Hosui A, Ishida H, Tatsumi T, Kanto T, Hiramatsu N, Fujita N, Yoshimori T, Hayashi N.
    Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma.
    Int J Cancer2012;131:548-57.
  19. Tsunematsu H, Tatsumi T, Kohga K, Yamamoto M, Aketa H, Miyagi T, Hosui A, Hiramatsu N, Kanto T, Hayashi N, Takehara T.
    Fibroblast growth factor-2 enhances NK sensitivity of hepatocellular carcinoma cells.
    Int J Cancer. 2012;130:356-64.